questionsmedicales.fr
Maladies urogénitales
Maladies urologiques
Maladies du rein
Diabète insipide néphrogénique
Diabète insipide néphrogénique : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Diabète insipide néphrogénique : Questions médicales les plus fréquentes",
"headline": "Diabète insipide néphrogénique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Diabète insipide néphrogénique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-30",
"dateModified": "2025-04-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Diabète insipide néphrogénique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies du rein",
"url": "https://questionsmedicales.fr/mesh/D007674",
"about": {
"@type": "MedicalCondition",
"name": "Maladies du rein",
"code": {
"@type": "MedicalCode",
"code": "D007674",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C12.950.419"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Diabète insipide néphrogénique",
"alternateName": "Diabetes Insipidus, Nephrogenic",
"code": {
"@type": "MedicalCode",
"code": "D018500",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Daniel G Bichet",
"url": "https://questionsmedicales.fr/author/Daniel%20G%20Bichet",
"affiliation": {
"@type": "Organization",
"name": "Departments of Medicine, Pharmacology and Physiology, Université de Montréal, Montréal, Québec, Canada."
}
},
{
"@type": "Person",
"name": "Francesco Trepiccione",
"url": "https://questionsmedicales.fr/author/Francesco%20Trepiccione",
"affiliation": {
"@type": "Organization",
"name": "Department of Translational Medical Sciences, University of Campania \"L.Vanvitelli\", Naples,Italy."
}
},
{
"@type": "Person",
"name": "Detlef Bockenhauer",
"url": "https://questionsmedicales.fr/author/Detlef%20Bockenhauer",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK."
}
},
{
"@type": "Person",
"name": "Takayasu Mori",
"url": "https://questionsmedicales.fr/author/Takayasu%20Mori",
"affiliation": {
"@type": "Organization",
"name": "Department of Nephrology, Tokyo Medical and Dental University, Fukui, Japan."
}
},
{
"@type": "Person",
"name": "Robert Kleta",
"url": "https://questionsmedicales.fr/author/Robert%20Kleta",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Deep Learning Powered Identification of Differentiated Early Mesoderm Cells from Pluripotent Stem Cells.",
"datePublished": "2024-03-18",
"url": "https://questionsmedicales.fr/article/38534378",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells13060534"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deep learning for automatic prediction of early activation of treatment naïve non-exudative MNVs in AMD.",
"datePublished": "2024-03-14",
"url": "https://questionsmedicales.fr/article/38489765",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/IAE.0000000000004106"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deep learning-based predictive classification of functional subpopulations of hematopoietic stem cells and multipotent progenitors.",
"datePublished": "2024-03-13",
"url": "https://questionsmedicales.fr/article/38475857",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13287-024-03682-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Enabling large-scale screening of Barrett's esophagus using weakly supervised deep learning in histopathology.",
"datePublished": "2024-03-11",
"url": "https://questionsmedicales.fr/article/38467600",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-024-46174-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Enhancing parasitic organism detection in microscopy images through deep learning and fine-tuned optimizer.",
"datePublished": "2024-03-08",
"url": "https://questionsmedicales.fr/article/38459096",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-56323-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies urogénitales",
"item": "https://questionsmedicales.fr/mesh/D000091642"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies urologiques",
"item": "https://questionsmedicales.fr/mesh/D014570"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies du rein",
"item": "https://questionsmedicales.fr/mesh/D007674"
},
{
"@type": "ListItem",
"position": 5,
"name": "Diabète insipide néphrogénique",
"item": "https://questionsmedicales.fr/mesh/D018500"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Diabète insipide néphrogénique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Diabète insipide néphrogénique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Diabète insipide néphrogénique",
"description": "Comment diagnostiquer le diabète insipide néphrogénique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels symptômes indiquent un diabète insipide néphrogénique ?\nComment différencier les types de diabète insipide ?\nQuel rôle joue l'imagerie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D018500?mesh_terms=Deep+Learning&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Diabète insipide néphrogénique",
"description": "Quels sont les principaux symptômes du diabète insipide néphrogénique ?\nLa soif est-elle un symptôme fréquent ?\nPeut-on avoir des symptômes sans polyurie ?\nComment la déshydratation se manifeste-t-elle ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D018500?mesh_terms=Deep+Learning&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Diabète insipide néphrogénique",
"description": "Peut-on prévenir le diabète insipide néphrogénique ?\nY a-t-il des mesures préventives spécifiques ?\nLes antécédents familiaux influencent-ils la prévention ?\nLes examens réguliers sont-ils recommandés ?\nL'éducation des patients est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D018500?mesh_terms=Deep+Learning&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Diabète insipide néphrogénique",
"description": "Quel est le traitement principal du diabète insipide néphrogénique ?\nLes médicaments peuvent-ils aider à gérer les symptômes ?\nY a-t-il des traitements non médicamenteux ?\nLes traitements sont-ils efficaces à long terme ?\nQuelles sont les options pour les cas réfractaires ?",
"url": "https://questionsmedicales.fr/mesh/D018500?mesh_terms=Deep+Learning&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Diabète insipide néphrogénique",
"description": "Quelles complications peuvent survenir ?\nComment la déshydratation affecte-t-elle la santé ?\nLes infections urinaires sont-elles fréquentes ?\nLes déséquilibres électrolytiques sont-ils préoccupants ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D018500?mesh_terms=Deep+Learning&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Diabète insipide néphrogénique",
"description": "Quels sont les facteurs de risque du diabète insipide néphrogénique ?\nLes maladies génétiques augmentent-elles le risque ?\nLes médicaments peuvent-ils être un facteur de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D018500?mesh_terms=Deep+Learning&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le diabète insipide néphrogénique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests d'urine et des analyses sanguines pour évaluer la concentration."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des tests de restriction hydrique et des dosages de l'hormone antidiurétique."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un diabète insipide néphrogénique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une soif excessive et une production d'urine très diluée."
}
},
{
"@type": "Question",
"name": "Comment différencier les types de diabète insipide ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "On compare les réponses aux tests d'hydratation et d'hormones pour identifier le type."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'imagerie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à identifier des anomalies structurelles des reins ou de l'hypophyse."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux symptômes du diabète insipide néphrogénique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux symptômes sont la polyurie, la polydipsie et la déshydratation."
}
},
{
"@type": "Question",
"name": "La soif est-elle un symptôme fréquent ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la soif excessive est un symptôme majeur en raison de la perte d'eau."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans polyurie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, car la polyurie est généralement présente avec d'autres symptômes."
}
},
{
"@type": "Question",
"name": "Comment la déshydratation se manifeste-t-elle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par une sécheresse de la bouche, de la fatigue et des étourdissements."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier, les enfants peuvent présenter des signes plus marqués."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le diabète insipide néphrogénique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais éviter les médicaments néphrotoxiques peut aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives spécifiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter la déshydratation et surveiller les symptômes sont des mesures préventives importantes."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux peuvent augmenter le risque, nécessitant une vigilance accrue."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils recommandés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des problèmes rénaux."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les symptômes et la gestion est cruciale pour la prévention."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du diabète insipide néphrogénique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal inclut des diurétiques thiazidiques et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à gérer les symptômes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent réduire la production d'urine et améliorer la soif."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non médicamenteux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation régulière et l'ajustement de l'alimentation sont des approches non médicamenteuses."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces à long terme ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent être efficaces, mais nécessitent un suivi régulier pour ajustements."
}
},
{
"@type": "Question",
"name": "Quelles sont les options pour les cas réfractaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pour les cas réfractaires, des traitements expérimentaux ou des thérapies géniques peuvent être envisagés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la déshydratation sévère, les déséquilibres électrolytiques et les infections."
}
},
{
"@type": "Question",
"name": "Comment la déshydratation affecte-t-elle la santé ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation peut entraîner des problèmes rénaux, des troubles cardiaques et des chutes."
}
},
{
"@type": "Question",
"name": "Les infections urinaires sont-elles fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections urinaires peuvent survenir en raison de l'excès d'urine et de la stagnation."
}
},
{
"@type": "Question",
"name": "Les déséquilibres électrolytiques sont-ils préoccupants ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer des problèmes cardiaques et neurologiques graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une gestion adéquate des symptômes et un suivi médical régulier aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du diabète insipide néphrogénique ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies rénales et certains médicaments."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques augmentent-elles le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies génétiques peuvent prédisposer au diabète insipide néphrogénique."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils être un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments comme le lithium peuvent provoquer un diabète insipide néphrogénique."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge peut influencer le risque, mais le diabète insipide néphrogénique peut survenir à tout âge."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies rénales ou d'hypophyse augmentent le risque."
}
}
]
}
]
}
Pluripotent stem cells can be differentiated into all three germ-layers including ecto-, endo-, and mesoderm in vitro. However, the early identification and rapid characterization of each germ-layer i...
Around 30% of non-exudative macular neovascularizations(NE-MNVs) exudate within 2 years from diagnosis in patients with age-related macular degeneration(AMD).The aim of the study is to develop a deep ...
AMD patients showing OCTA and fluorescein angiography (FA) documented NE-MNV with a 2-years minimum imaging follow-up were retrospectively selected. Patients showing OCT B-scan-documented MNV exudatio...
Eighty-nine (89) eyes of 89 patients with a follow-up of 5.7 ± 1.5 years were recruited(35 EX GROUP and 54 QU GROUP). Inception-ResNet-v2 was the best performing among the 3 single convolutional neura...
Artificial intelligence shows high performances in identifications of NE-MNVs at risk for exudation within the first 2 years of follow up, allowing better customization of follow up timing and avoidin...
Hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs) play a pivotal role in maintaining lifelong hematopoiesis. The distinction between stem cells and other progenitors, as well as the a...
In this study, we explored the feasibility of employing deep learning techniques to differentiate murine HSCs and MPPs based solely on their morphology, as observed through light microscopy (DIC) imag...
After rigorous training and validation using extensive image datasets, we successfully developed a three-class classifier, referred to as the LSM model, capable of reliably distinguishing long-term HS...
Our study represents the pioneering use of deep learning to differentiate HSCs and MPPs under steady-state conditions. This novel and robust deep learning-based platform will provide a basis for the f...
Timely detection of Barrett's esophagus, the pre-malignant condition of esophageal adenocarcinoma, can improve patient survival rates. The Cytosponge-TFF3 test, a non-endoscopic minimally invasive pro...
Parasitic organisms pose a major global health threat, mainly in regions that lack advanced medical facilities. Early and accurate detection of parasitic organisms is vital to saving lives. Deep learn...
Recent GWASs have demonstrated that comorbid disorders share genetic liabilities. But whether and how these shared liabilities can be used for the classification and differentiation of comorbid disord...
Acute ischemic stroke (AIS) is a leading global cause of mortality and morbidity. Improving long-term outcome predictions after thrombectomy can enhance treatment quality by supporting clinical decisi...
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6is) have revolutionized breast cancer therapy. However, <50% of patients have an objective response, and nearly all patients develop resistance during...
Breast cancer is the most common malignancy among women worldwide. Despite advances in treating breast cancer over the past decades, drug resistance and adverse effects remain challenging. Recent ther...
This study developed a deep neural network model that predicts synergy between small-molecule pairs based on their inhibitory activities against 13 selected key proteins. The synergy prediction model ...
The framework employed in the present study lays the groundwork for future advancements, especially in model interpretation. By combining deep learning techniques and target-specific models, this stud...
Atypical presentations, lack of biomarkers, and low sensitivity of plain CT can delay the diagnosis of superior mesenteric artery (SMA) abnormalities, resulting in poor clinical outcomes. Our study ai...
A total of 1048 patients comprised the internal (474 patients with SMA abnormalities, 474 controls) and external testing (50 patients with SMA abnormalities, 50 controls) cohorts. The internal cohort ...
Of the submodels, YOLOv8x had the best performance. The area under the curve (AUC) of the YOLOv8x submodel was higher than that of the clinical model (internal test set: 0.990 vs 0.878, P =.002; exter...
Using plain CT images, YOLOv8x was able to efficiently identify cases of SMA abnormalities. This could potentially improve early diagnosis accuracy and thus improve clinical outcomes....